VolitionRx collaborates with Sysmex to transfer Nu.Q NETs assay onto Sysmex platform

Reuters2026/08/26 13:17

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

VolitionRx transferred its Nu.Q NETs assay onto Sysmex’s platform, setting up talks on a broader commercial agreement.
Move positions the sepsis-focused test for potential deployment on Sysmex analyzers, strengthening licensing prospects with major diagnostics groups.
Update also cited active licensing discussions with more than a dozen global diagnostic and liquid biopsy companies.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VolitionRX Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608260917PR_NEWS_USPR_____LN34057) on August 26, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

VolitionRx collaborates with Sysmex to transfer Nu.Q NETs assay onto Sysmex platform

You may also like

Crypto prices